A detailed history of Headlands Technologies LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Headlands Technologies LLC holds 25,482 shares of ITCI stock, worth $1.96 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
25,482
Previous 468 5344.87%
Holding current value
$1.96 Million
Previous $32,000 5353.13%
% of portfolio
0.19%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$64.76 - $79.84 $1.62 Million - $2 Million
25,014 Added 5344.87%
25,482 $1.75 Million
Q1 2024

May 07, 2024

BUY
$64.37 - $75.65 $30,125 - $35,404
468 New
468 $32,000
Q3 2023

Nov 09, 2023

BUY
$52.09 - $64.1 $103,242 - $127,046
1,982 Added 96.92%
4,027 $209,000
Q2 2023

Aug 03, 2023

BUY
$54.67 - $66.44 $111,800 - $135,869
2,045 New
2,045 $129,000

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $7.25B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Headlands Technologies LLC Portfolio

Follow Headlands Technologies LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Headlands Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Headlands Technologies LLC with notifications on news.